Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
Weizmann Institute of Science · Broad Institute · +16 more institutions
Indexed incrossrefpubmed
Abstract
Expression, and abrogated by cotreatment with the antibiotic ciprofloxacin. Gemcitabine is commonly used to treat pancreatic ductal adenocarcinoma (PDAC), and we hypothesized that intratumor bacteria might contribute to drug resistance of these tumors. Consistent with this possibility, we found that of the 113 human PDACs that were tested, 86 (76%) were positive for bacteria, mainly Gammaproteobacteria.
Citation impact
1,740
total citations
- FWCI
- 40.59
- Percentile
- 100%
- References
- 30
Citations per year
Authors
47Topics & keywords
Topics
Keywords
- Gemcitabine
- Drug resistance
- Drug
- Bacteria
- Chemotherapeutic drugs
- Cancer research
- Biology
- Pharmacology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.